Vacuum blood collection vessel is a kind of blood collection container. It was first invented during the Second World War in 1937. It began commercial production in Europe and America in 1943, introduced in Japan in 1964 and applied to clinical blood collection in 1971.

In 1991, Hunan Liuyang medical instrument factory produced the first vacuum blood collection vessel in China and began clinical promotion. In 1999, the State Food and Drug Administration issued the mandatory industry standard yy0314-1999 disposable venous blood collection container, marking the orderly development of China's vacuum blood collection vessel manufacturing industry.

The 24 years from 1991 to 2015 and from 1991 to 2015 can be roughly divided into three stages.

The first eight years from the birth of China's first vacuum blood collection vessel in 1991 to the first eight years in 1998 were the initial stage of the industry. During this period, China's vacuum blood collection vessel industry grew from nothing and experienced the stage of pure manual production to semi-automatic assembly.

In 1999, the former State Food and Drug Administration promulgated the yy0314 industry standard. The second eight years from this year to 2007 belong to the growth period of the vacuum blood collection industry. Since the former Ministry of Health issued WS / t225-2002 collection and treatment of blood samples for clinical chemical examination, it is clearly stipulated that the blood samples used for chemical examination must be vacuum blood collection vessels. According to the characteristics of China's vacuum blood collection industry, domestic upstream enterprises have launched a series of special equipment for blood collection manufacturing, which has rapidly promoted the automatic production of vacuum blood collection, and social capital has begun to enter this field one after another. By the end of 2007, there were more than 30 manufacturers of vacuum blood collection vessels in China, with a production and sales volume of 1.2 billion.

The eight years from 2008 to 2015 were a period of rapid development of China's vacuum blood collection industry. The number of enterprises increased rapidly and the investment scale expanded continuously. There were companies listed on the gem (Guangzhou Yangpu, 30030), three companies listed on the new third board (Ruiqi technology 831079, Xinle medical 83294, Yaohua medical 833141) and many listed companies (such as Kehua biological 002022, Kelun pharmaceutical 00242, Qianshan pharmaceutical machinery 300216, Yuyue medical 00223, Changhong technology 300151, etc.) establish subsidiaries.

Upstream and downstream enterprises in the vacuum blood collection industry have emerged one after another, and their scale has gradually expanded. In 2015, there were 115 vacuum blood collection manufacturers in China, with production sales of nearly 5 billion tubes. In addition to a large number of exports of vacuum blood collection, peripheral products such as automatic vacuum blood collection production line, special butyl rubber plug for blood collection, blood collection embryo and venous blood collection needle also occupied part of the international market 。

At this time, foreign capital also began to favor the Chinese market. Japan's Shuishui, Taiermao, niplo and American BD successively invested and built factories in China and established production bases in Beijing, Hangzhou, Shanghai and Suzhou respectively.